-Nigerian researcher announces cure for HIV/AIDS.
-He urges the federal government to set up a committee to carry out clinical trials for the research discovery.
A Nigerian researcher, Prof. Madubuike Ezeibe, has on Monday, invited the federal government of Nigeria to carry out a clinical trial of the drug he invented, Aluminum-Magnesium Silicate (AMS), for the treatment of HIV/AIDS.
Ezeibe, is a professor of Veterinary Medicine at the Michael Okpara University of Agriculture, Umudike (MOUAU), Abia state.
Having presented a paper on the potential of the drug as both antiviral and raw material, at a world conference on Ethnopharmacology in Chicago, United States, on May 2, 2016, the don is sure the stage is set for a clinical trial of the drugs.
He said that more than one year after he invented and presented his findings at different international conferences, no authority anywhere in the world had disputed the research findings.
“I therefore appeal to the federal government to institute an inter-ministerial committee to carry out clinical trial of the drug in six centres across the country without further delay.
READ ALSO: HIV/AIDS Prevalence: Nigeria ranks second globally
“The committee should comprise federal Ministries of Health, Education, Environment as well as Science and Technology, with, at least, 1000 sample patients from each state of the federation.
“Some of the findings of the research include that silicates have molecules that are 0.96 nanometer in size while HIV has molecules as big as 110 nanometer.
“The particles of AMS are positively and negatively charged, while HIV-infected cells are positively charged.
“The AMS are immune stimulants; one can use simple sugar (glucose) to transport charged molecules across the mucus membrane to the blood.
“Glucose helps to transport the drug to any part of the body, including ‘the sanctuary’, where other drugs cannot reach to attack the HIV-infected cells.
“So, if these findings are true and nobody has challenged the claims of the research, let the federal government set up an inter-ministerial committee to conduct clinical trial of the medicine,’’ he said.
Ezeibe expressed confidence the drugs will pass the clinical stage and commended the University authorities as well as the Abia state government for their support so far.
He stated several referred cases have already been successfully treated.
“All the HIV cases were referral from a medical doctor to the Medical Director of MOUAU. I have also handled referrals from different parts of African and Asian continents,’’ Ezeibe said.